Dharmarajan Sriram

847 total citations
12 papers, 700 citations indexed

About

Dharmarajan Sriram is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Dharmarajan Sriram has authored 12 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Dharmarajan Sriram's work include Synthesis and biological activity (5 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer therapeutics and mechanisms (2 papers). Dharmarajan Sriram is often cited by papers focused on Synthesis and biological activity (5 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Cancer therapeutics and mechanisms (2 papers). Dharmarajan Sriram collaborates with scholars based in India. Dharmarajan Sriram's co-authors include Perumal Yogeeswari, Tanushree Ratan Bal, R. Thirumurugan, Aruna Malapati, Khushal M. Kapadiya, Balaji Gowrivel Vijayakumar, Tharanikkarasu Kannan, Shankar Gharge, Sunil Jalalpure and Gamidi Rama Krishna and has published in prestigious journals such as Current Medicinal Chemistry, New Journal of Chemistry and Journal of Molecular Structure.

In The Last Decade

Dharmarajan Sriram

12 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dharmarajan Sriram India 6 501 109 73 57 53 12 700
Asma Ismail Mahmod Jordan 13 294 0.6× 103 0.9× 47 0.6× 78 1.4× 59 1.1× 24 742
Hyo Jin Lim South Korea 14 333 0.7× 214 2.0× 68 0.9× 74 1.3× 54 1.0× 22 660
Namki Cho South Korea 16 429 0.9× 146 1.3× 94 1.3× 56 1.0× 121 2.3× 68 865
Yingli Wang China 16 256 0.5× 78 0.7× 37 0.5× 23 0.4× 33 0.6× 53 696
Yin-Quan Tang Malaysia 14 276 0.6× 131 1.2× 61 0.8× 38 0.7× 83 1.6× 39 748
Amin Iranpanah Iran 14 270 0.5× 86 0.8× 35 0.5× 42 0.7× 81 1.5× 23 709
Seung‐Hoon Choi South Korea 19 484 1.0× 157 1.4× 55 0.8× 63 1.1× 121 2.3× 36 1.0k
Chun‐Chi Kuo Taiwan 15 292 0.6× 83 0.8× 40 0.5× 25 0.4× 34 0.6× 61 600

Countries citing papers authored by Dharmarajan Sriram

Since Specialization
Citations

This map shows the geographic impact of Dharmarajan Sriram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharmarajan Sriram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharmarajan Sriram more than expected).

Fields of papers citing papers by Dharmarajan Sriram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dharmarajan Sriram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharmarajan Sriram. The network helps show where Dharmarajan Sriram may publish in the future.

Co-authorship network of co-authors of Dharmarajan Sriram

This figure shows the co-authorship network connecting the top 25 collaborators of Dharmarajan Sriram. A scholar is included among the top collaborators of Dharmarajan Sriram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dharmarajan Sriram. Dharmarajan Sriram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
3.
Ramesh, Deepthi, et al.. (2023). Novel pyrimidine – Imines against tuberculosis: Rationale, in vitro, in silico studies and mechanistic insights. Journal of Molecular Structure. 1292. 136183–136183. 2 indexed citations
4.
Ramesh, Deepthi, et al.. (2023). Novel Pyrimidine – Imines Against Tuberculosis: Rationale, In Vitro, In Silico Studies and Mechanistic Insights. SSRN Electronic Journal. 1 indexed citations
6.
Sriram, Dharmarajan, et al.. (2022). Metal Catalyst-Free One-pot Synthesis of Carboxamide Derivatives viaUgi-4CC Reaction and Its Anti-tubercular Study. Letters in Drug Design & Discovery. 21(2). 226–235. 4 indexed citations
7.
Malapati, Aruna, et al.. (2015). A Review on GABA/Glutamate Pathway for Therapeutic Intervention of ASD and ADHD. Current Medicinal Chemistry. 22(15). 1850–1859. 50 indexed citations
8.
Sriram, Dharmarajan, et al.. (2014). Future Directions in the Treatment of Neuropathic Pain: A Review on Various Therapeutic Targets. CNS & Neurological Disorders - Drug Targets. 13(1). 63–81. 21 indexed citations
9.
Sriram, Dharmarajan, et al.. (2013). Potential Role of Rho Kinase Inhibitors in Combating Diabetes-Related Complications Including Diabetic Neuropathy-A Review. Current Diabetes Reviews. 9(3). 249–266. 24 indexed citations
10.
Yogeeswari, Perumal, et al.. (2009). Current approaches with the glutamatergic system as targets in the treatment of neuropathic pain. Expert Opinion on Therapeutic Targets. 13(8). 925–943. 14 indexed citations
11.
Yogeeswari, Perumal & Dharmarajan Sriram. (2005). Betulinic Acid and Its Derivatives: A Review on their Biological Properties. Current Medicinal Chemistry. 12(6). 657–666. 453 indexed citations
12.
Sriram, Dharmarajan, et al.. (2005). Camptothecin and its analogues: a review on their chemotherapeutic potential. Natural Product Research. 19(4). 393–412. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026